Telling our stories: Bidirectional benefits of sharing our history

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

The views expressed here are those of Kimryn Rathmell alone.  Dear Colleagues, By the time many of you read this, it will be March! That means warmer weather as well as orange lights and #OrangeUp signs in recognition of Kidney Cancer Awareness Month! I’m always excited to bring out my orange (and green—for those who...

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
W. Kimryn Rathmell, MD, PhD, MMHC
Former director, National Cancer Institute
Table of Contents

YOU MAY BE INTERESTED IN

In December 1971, President Richard Nixon signed the National Cancer Act and declared a “War on Cancer.” In the past 54 years, the U.S. has invested $180 billion nominally, or approximately $322 billion when adjusted for inflation, in cancer research. This investment has paid dividends with more than 100 anticancer drugs brought to market in half a century—virtually all traceable to National Cancer Institute funding. 
W. Kimryn Rathmell, MD, PhD, MMHC
Former director, National Cancer Institute

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login